#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant neoplasm of choroid Thrombocytopenia Glomerulonephritis Immunodeficiency common variable Marginal zone lymphoma ABO haemolytic disease of newborn Atypical haemolytic uraemic syndrome Haemophagocytic lymphohistiocytosis Congenital myopathy Hypocalcaemia Obliterative bronchiolitis Li-Fraumeni syndrome Colitis ulcerative Interstitial lung disease Hereditary ataxia More trials…

    Learn about Rare Diseases

    Loeys-Dietz syndrome Myxofibrosarcoma – Diagnostics Nodal marginal zone B-cell lymphoma Wolfram syndrome Adrenogenital syndrome – Treatment Glomerulonephritis membranoproliferative Ehlers-Danlos syndrome Niemann-Pick disease – Treatment Mantle cell lymphoma stage IV – Basic Information Hyperoxaluria – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Haloperidol Decanoate Siponimod Lurbinectedin Urokinase Dmd06-Mab Tigulixostat Colistin Sulfate Seralutinib Lacosamide Dimeticone Psma-11 Cefuroxime Omp72 Isavuconazonium Sulfate Pal1-15 Acetate Fostemsavir Trometamol Ict01 RNMB3 L-ARGININE Venetoclax More therapies…

    Learn about Your Condition

    Endocarditis enterococcal Cluster headache Agitation postoperative Nephrogenic anaemia Hypochondroplasia Hepatic neoplasm Eye inflammation Pericarditis Pancreatic carcinoma recurrent Renal impairment Lip and/or oral cavity cancer Arthritis infective Cancer pain Infective uveitis Myofascial pain syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Rouen, 76000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Brensocatib for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    2 1
    Investigated Drugs:
    • BRENSOCATIB
    Bulgaria France Germany Greece The Netherlands Poland +1

  • Study of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Sonelokimab
    Bulgaria Croatia Czechia Estonia Finland France +10

  • Study on the Effects of Inhaled Treprostinil for Patients with Progressive Pulmonary Fibrosis

    Not recruiting

    3 1
    Investigated Diseases:
    • Pulmonary fibrosis
    Investigated Drugs:
    • Treprostinil
    Belgium France Germany Italy Spain

  • Study on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Zasocitinib
    Bulgaria Czechia France Germany Hungary Italy +3

  • Study on the Effectiveness of AVTX-009 for Treating Moderate to Severe Hidradenitis Suppurativa in Patients

    Not recruiting

    2 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • AVTX-009
    Bulgaria Czechia France Germany Greece Italy +3

  • Study on Ketamine and Magnesium Sulfate for Treating Chronic Cluster Headache in Patients Unresponsive to Standard Treatments

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Cluster headache
    Investigated Drugs:
    • Hydroxyzine Hydrochloride
    • Ketamine Hydrochloride
    • Magnesium Sulfate Heptahydrate
    France

  • Study of rituximab and belimumab combination compared to rituximab alone in adults with persistent or chronic immune thrombocytopenia (ITP)

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Belimumab
    France

  • Study of gemtuzumab ozogamicin and chemotherapy combinations in children with newly diagnosed acute myeloid leukemia, high-risk myelodysplastic syndrome, or myeloid sarcoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Busulfan
    • Gemtuzumab Ozogamicin
    • Cyclophosphamide
    France Ireland

  • Study of Isatuximab for Patients with Type I Cryoglobulinemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cryoglobulinaemia
    Investigated Drugs:
    • Isatuximab
    France

  • Study on the Safety and Effectiveness of Domvanalimab, Zimberelimab, and Quemliclustat in Adults with Advanced Upper Gastrointestinal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastrointestinal carcinoma
    Investigated Drugs:
    • Domvanalimab
    • Quemliclustat
    • Zimberelimab
    France
Previous Page
1 … 29 30 31 32 33 … 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!